Draper Associates

Avarra uses AI simulations and realistic avatars to help go-to-market teams practice customer conversations and improve their skills.

Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical.

Poseidon Aerospace is developing unmanned cargo aircraft for commercial freight and defense logistics. Its Egret short-takeoff-and-landing freighter and Heron seaplane are designed to move heavy loads between small, remote or water-based operating sites without an onboard pilot.

Develops AI-powered autonomous directed-energy systems to detect and neutralize drone threats

Building next-generation propulsion systems for defense, space, and future high-speed flight

Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine

Automates disaster recovery and resilience testing for enterprises running complex cloud environments on AWS and Azure

Apoha measures molecular behavior for pharmaceutical, food and materials research.

Casimir is developing semiconductor chips intended to supply power without conventional batteries.

Develops AI foundation models that translate commander intent into coordinated unmanned system action

Builds AI orchestration software and autonomous agents for defense and intelligence operations

Develops AI-driven drug discovery platform for first- and best-in-class therapeutics

Develops hyper-efficient blended-wing aircraft for commercial and defense aviation

Builds AI agents that function as autonomous founders to create and scale startups